Association of Polypharmacy and Anticholinergic Burden with Length of Stay in Hospital Amongst Older Adults Admitted with Hip Fractures: A Retrospective Observational Study.
Drugs
Health economics
Hospital discharge
Mobility
Pressure ulcers
Journal
Calcified tissue international
ISSN: 1432-0827
Titre abrégé: Calcif Tissue Int
Pays: United States
ID NLM: 7905481
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
25
01
2023
accepted:
20
02
2023
medline:
18
4
2023
pubmed:
11
3
2023
entrez:
10
3
2023
Statut:
ppublish
Résumé
Age-associated multimorbidity and polypharmacy, predispose individuals to falls and consequent hip fractures. We examined the impact of polypharmacy (≥ 4 drugs daily), including anticholinergic agents, on hospital length of stay (LOS), mobility within 1-day of hip surgery and pressure ulcers in adults ≥ 60 years admitted with hip fractures. In this retrospective observational study, information on medications at admission was obtained to calculate the total number of drugs taken, including those imposing an anticholinergic burden (ACB). Associations between variables were examined by logistic regression; adjusted for age, sex, co-morbidities, pre-fracture functional limitations and alcohol consumption. There were 787 women and 318 men of similar mean age (± SD): 83.1 years (± 8.6) and 82.5 years (± 9.0), respectively. Compared to patients with an ACB score = 0 and taking < 4 drugs daily, those with an ACB score ≥ 1 and taking ≥ 4 drugs daily had greater risk of prolonged LOS (≥ 2 weeks), OR 1.8 (1.2-2.7); failure to mobilise within 1-day of surgery, OR 1.9 (1.1-3.3); and pressure ulcers, OR 3.0 (95% CI 1.2-7.9). LOS was further prolonged by failure to mobilise within 1-day of surgery and/or pressure ulcers. Those with either an ACB score ≥ 1 or the use of ≥ 4 drugs daily had intermediate risks. Anticholinergic agents and polypharmacy in patients with hip fractures are associated with longer LOS in hospital, further accentuated by failure to mobilise within 1-day after surgery and pressure ulcers. This study provides further evidence of the impact of polypharmacy, including those with an ACB, on adverse health outcomes and lends support to reduce potentially inappropriate prescribing.
Sections du résumé
BACKGROUND
Age-associated multimorbidity and polypharmacy, predispose individuals to falls and consequent hip fractures. We examined the impact of polypharmacy (≥ 4 drugs daily), including anticholinergic agents, on hospital length of stay (LOS), mobility within 1-day of hip surgery and pressure ulcers in adults ≥ 60 years admitted with hip fractures.
METHODS
In this retrospective observational study, information on medications at admission was obtained to calculate the total number of drugs taken, including those imposing an anticholinergic burden (ACB). Associations between variables were examined by logistic regression; adjusted for age, sex, co-morbidities, pre-fracture functional limitations and alcohol consumption.
RESULTS
There were 787 women and 318 men of similar mean age (± SD): 83.1 years (± 8.6) and 82.5 years (± 9.0), respectively. Compared to patients with an ACB score = 0 and taking < 4 drugs daily, those with an ACB score ≥ 1 and taking ≥ 4 drugs daily had greater risk of prolonged LOS (≥ 2 weeks), OR 1.8 (1.2-2.7); failure to mobilise within 1-day of surgery, OR 1.9 (1.1-3.3); and pressure ulcers, OR 3.0 (95% CI 1.2-7.9). LOS was further prolonged by failure to mobilise within 1-day of surgery and/or pressure ulcers. Those with either an ACB score ≥ 1 or the use of ≥ 4 drugs daily had intermediate risks.
CONCLUSIONS
Anticholinergic agents and polypharmacy in patients with hip fractures are associated with longer LOS in hospital, further accentuated by failure to mobilise within 1-day after surgery and pressure ulcers. This study provides further evidence of the impact of polypharmacy, including those with an ACB, on adverse health outcomes and lends support to reduce potentially inappropriate prescribing.
Identifiants
pubmed: 36899089
doi: 10.1007/s00223-023-01072-5
pii: 10.1007/s00223-023-01072-5
doi:
Substances chimiques
Cholinergic Antagonists
0
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
584-591Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
United Nations Department of Economic and Social Affairs Population Division. World population ageing 2013. http://www.un.org/en/development/desa/population/publications/pdf . Accessed 15 Jan 2023
Dharmarajan K, Strait KM, Tinetti ME et al (2016) Treatment for multiple acute cardiopulmonary conditions in older adults hospitalized with pneumonia, chronic obstructive pulmonary disease, or heart failure. J Am Geriatr Soc 64:1574–1582
doi: 10.1111/jgs.14303
pubmed: 27448329
pmcid: 4988873
Fuller GF (2000) Falls in the elderly. Am Fam Physician 61:2159–2168
pubmed: 10779256
Mair A, Wilson M, Dreischulte T (2020) Addressing the challenge of polypharmacy. Annu Rev Pharmacol Toxicol 60:661–681
doi: 10.1146/annurev-pharmtox-010919-023508
pubmed: 31589822
Judge A, Javaid MK, Leal J et al (2016) Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England. Health Serv Deliv Res. https://doi.org/10.3310/hsdr04280
doi: 10.3310/hsdr04280
Castelli A, Daidone S, Jacobs R, Kasteridis P, Street AD (2015) The determinants of costs and length of stay for hip fracture patients. PLoS ONE 10:e0133545
doi: 10.1371/journal.pone.0133545
pubmed: 26204450
pmcid: 4512684
Royal College of Physicians. NHFD annual report 2019. https://www.rcplondon.ac.uk/projects/outputs/nhfd-annual-report-2019
Spinewine A, Schmader KE, Barber N et al (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370:173–184
doi: 10.1016/S0140-6736(07)61091-5
pubmed: 17630041
Wise J (2013) Polypharmacy: a necessary evil. BMJ 347:f7033
doi: 10.1136/bmj.f7033
pubmed: 24286985
Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K (2010) Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol 69:543–552
doi: 10.1111/j.1365-2125.2010.03628.x
pubmed: 20573091
pmcid: 2856056
Lu WH, Wen YW, Chen LK, Hsiao FY (2015) Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. CMAJ 187:E130–E137
doi: 10.1503/cmaj.141219
pubmed: 25646290
pmcid: 4347788
Salahudeen MS, Hilmer SN, Nishtala PS (2015) Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. J Am Geriatr Soc 63:85–90
doi: 10.1111/jgs.13206
pubmed: 25597560
Liang CK, Chou MY, Hsu YH et al (2023) The association of potentially inappropriate medications, polypharmacy and anticholinergic burden with readmission and emergency room revisit after discharge: a hospital-based retrospective cohort study. Br J Clin Pharmacol 89:187–200
doi: 10.1111/bcp.15457
pubmed: 35821614
De Vincentis A, Gallo P, Finamore P et al (2020) Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? Drugs Aging 37:585–593
doi: 10.1007/s40266-020-00767-w
pubmed: 32445121
Hanlon P, Quinn TJ, Gallacher KI et al (2020) Assessing risks of polypharmacy involving medications with anticholinergic properties. Ann Fam Med 18:148–155
doi: 10.1370/afm.2501
pubmed: 32152019
pmcid: 7062487
National Audit Office (2016) Discharging older patients from hospital. Report by the Comptroller and Auditor General. NAO, London. http://www.nao.org.uk/wp-content/uploads/2015/12/Discharging-older-patients-from-hospital-Summary.pdf . Accessed 15 Jan 2023
Kaye KS, Marchaim D, Chen TY et al (2014) Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults. J Am Geriatr Soc 62:306–311
doi: 10.1111/jgs.12634
pubmed: 24438554
pmcid: 4037885
Han TS, Murray P, Robin J, Wilkinson P, Fluck D, Fry CH (2022) Evaluation of the association of length of stay in hospital and outcomes. Int J Qual Health Care 34:mzab160
pubmed: 34918090
Lisk R, Uddin M, Parbhoo A et al (2019) Predictive model of length of stay in hospital among older patients. Aging Clin Exp Res 31:993–999
doi: 10.1007/s40520-018-1033-7
pubmed: 30191455
World Health Organization (2004) ICD-10: international statistical classification of diseases and related health problems: tenth revision. WHO, Geneva
Yeong K, Lisk R, Watters H et al (2023) Pre-fracture mobility using standardized scale as an early indicator of high health risk in patients with a hip fracture. Ageing Int 48:301–315
doi: 10.1007/s12126-021-09468-0
Aging Brain Care. Anticholinergic cognitive burden scale. Regenstrief Institute, 2012. https://corumpharmacy.com/wp-content/uploads/2020/08/Anticholinergic-cognitive-burden-scale.pdf . Accessed 15 Jan 2023
Nakham A, Myint PK, Bond CM et al (2020) Interventions to reduce anticholinergic burden in adults aged 65 and older: a systematic review. J Am Med Dir Assoc 21:172–180
doi: 10.1016/j.jamda.2019.06.001
pubmed: 31351858
van der Meer HG, Wouters H, Pont LG, Taxis K (2018) Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial. BMJ Open 8:e019042
doi: 10.1136/bmjopen-2017-019042
pubmed: 30030308
pmcid: 6059312
Davies EA, O’mahony MS (2015) Adverse drug reactions in special populations–the elderly. Br J Clin Pharmacol 80:796–807
doi: 10.1111/bcp.12596
pubmed: 25619317
pmcid: 4594722
Lavan AH, Gallagher P (2016) Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf 7:11–22
doi: 10.1177/2042098615615472
pubmed: 26834959
pmcid: 4716390
Fox KM, Cummings SR, Williams E, Stone K, Study of Osteoporotic Fractures (2000) Femoral neck and intertrochanteric fractures have different risk factors: a prospective study. Osteoporos Int 11:1018–1023
doi: 10.1007/s001980070022
pubmed: 11256892